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Background: South Africa has a large HIV disease burden, with the highest rate of infection occurring in 
young women of the childbearing age. This gave impetus to the Prevention-of-Mother-To-Child-Transmission 
(PMTCT) program, that has been successfully implemented. Due to the success of the PMTCT program, HIV-
exposed-uninfected (HEU) infants represent a growing population in South Africa. However, these infants 
have been found to have increased morbidity and mortality rates compared to their HIV Unexposed 
Uninfected (HUU) peers, as well as altered immune and vaccine responses. The reasons for this remain 
unclear, but one hypothesis is that altered gut microbiomes in HEU adversely affect the developing infant 
immune system. The microbiome (a collection of an array of microorganisms, their genes, genomes, 
proteomes, and metabolites) is an area of emerging research interest; dysbiosis of the gut microbiome has 
recently been associated with disease outcomes and progression in several disease areas. The microbial 
colonisation of the infant begins in utero and continues after birth. It is affected by several factors: birth 
mode, age of gestation, feeding mode, maternal health status as well as environmental factors. 
Aim: To elucidate the microbiomes of HEU infants in Africa, compared to HUU controls 
 
Design: Ultra-high-performance liquid chromatography mass spectrometry was used to analyse and 
characterize a subset of existing stool samples stored from the InFANT cohort study. The infant gut 
metaproteome of 34 HEU versus 29 HUU infants, from the South African arm of the study was analysed. 
Cross-sectional samples were collected and analysed at two-time points, namely at birth and within the first 
week of life (between 4 to 7 days after birth).  
  
Results: Comparative analysis of the HEU and HUU reveal differences in the microbial composition between 
the two groups at birth and day 4-7, with the most apparent difference occurring at birth. In our comparison 
we found that the relative abundances of Bacteroidetes and Firmicutes were different between the HEU and 
HUU at both birth and day 4-7. There was a dramatic shift in the microbial composition within the first week 
of life.  
 
Conclusion: It is evident from our analysis that the HEU infant has a different gut microbiome to that of the 
HUU infant at birth. The HEU microbiome is characterised by a high microbial diversity at birth. This could be 
associated with more severe outcomes from childhood ailments. The human breast milk (HBM) microbiome 
greatly influences and mitigates the differences upon subsequent breastfeeding, but differences in the 
measured microbiomes of HEU and HUU nonetheless remain. 
 
Recommendations: A longitudinal study should be carried out to better monitor the long-term effects of the 
microbiome on infant immune priming. A study of the HBM microbiome should also be investigated to better 
understand the role of HBM in mediating and priming the infant’s immune system. Further, a study of the 
metabolome of the infant gut and the matching HBM of the mother may identify potential metabolites that 
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HIV in South Africa  
The trajectory of human immunodeficiency virus (HIV) infection in South Africa is different to other 
parts of the world, due to the socio-economic history in the country (Loewenson et al., 1997; 
Hargreaves et al., 2007; Weiser et al., 2007; CDC, 2016). In other parts of the world the majority of 
HIV infections occurred between men who have sex with men (MSM) or through the use of 
injectable drugs (El-Sadr, Mayer and Hodder, 2010; Aids, 2018), whereas the onset of the epidemic 
within the South African context saw a rapid rise in the rate of HIV infection and transmission among 
women of reproductive age between 25-35 years old (Williams et al., 2000). This further 
contributed to an increase in the number of HIV-infected and –exposed (HEU) infants born in South 
Africa. Hesseling and colleagues  observed that these HEU infants were immunocompromised at 
birth and suffered adverse side effects from routine vaccinations such as BCG (Hesseling et al., 2007, 
2009). These findings highlighted that we clearly do not understand the impact of HIV exposure and 
of Highly Active Antiretroviral Therapy (HAART) on immune development in HEU infants in utero 
(Garcia-Knight et al., 2015).  
In 2002, the South African government implemented a Prevention-of-Mother-to-child-transmission 
(PMTCT) program, which has grown into one of the world’s largest PMTCT programs (Goga et al., 
2017). Since its initiation the program has undergone several changes and the policy has been 
amended (Goga et al., 2017). In a bid to reduce the number of HIV positive babies born, the 
government changed the healthcare policies and mandated HIV testing for all pregnant women 
receiving prenatal care from a government facility (Doherty et al., 2010, 2011). Since 2013, if the 
mother tested HIV positive, she is placed on lifelong HAART treatment regardless of her CD4 count. 
The successful implementation of this intervention reduced the number of vertical transmission 
from mother-to-child by 78% (Burton, Giddy and Stinson, 2015; Sherman et al., 2017). As a result 
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of this, however, the number of HIV-exposed babies born in South Africa increased exponentially 
over the last few years (Anon, 2016).   
Despite the success of the program in preventing vertical transmission of the HIV from mother-to-
child, HEU infants are still experiencing adverse outcomes i.e. low birthweight, increased morbidity 
and mortality due to opportunistic infections, compared to  their HIV-unexposed-uninfected (HUU) 
peers (Ramokolo et al., 2014; Hofer et al., 2016; le Roux et al., 2016; Smith et al., 2017). Some of 
these poor health outcomes can be attributed to recommendations that were initially introduced 
by the World Health Organisation (WHO) and the  South African Department of Health and the 
National AIDS Council to exclusively formula feed (FF) HEU infants ,amongst  a number of factors  
(HIV and infant feeding Guidelines on, 2010; Sherman et al., 2017). In South Africa, most HIV positive 
mothers live in resource poor conditions and thus formula feeding is expensive, and the WHO 
recommendations did not consider the socio-economic status of these mothers. Therefore a large 
proportion of the poor health outcomes experienced by these HEU infants could be attributed to 
bad feeding practices, resulting in increased diarrheal diseases and infections such as oral thrush (le 
Roux et al., 2016). Issues related to access to clean water and sanitation are not unique to South 
Africa and indeed similar disease trends were also observed in other  low-income to middle income 
countries with high HIV disease burden thus leading to increased diarrheal illness and 
malnourishment (Powis et al., 2011; Gibb et al., 2012; Arikawa et al., 2016). A policy change in 2009 
by the WHO encouraged exclusive breastfeeding practices for HIV exposed/positive infants, 
regardless of the mothers HIV status, for the first 6 months of the infants life (Natchu et al., 2012). 
This recommendation greatly reduced the morbidity and mortality of HEU infants due to bad 
feeding practices (Wood et al., 2017): during  the first 6 months of life, protection against diarrhoea 
was substantially greater (odds ratio 6.1 [4.1-9.0]) than against deaths due to acute respiratory 
infection with exclusive breast feeding (Victora and Barros, 2000). Although the recommended 
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feeding practices have changed, only 50% of South African HIV positive mothers are choosing to 
exclusively breast feed for the first six months of the infant’s life, whilst the remainder are choosing 
to continue mix feeding practices of a combination of breastfeeding, formula feeding and solid 
foods (Coutsoudis, 2005; Kuhn et al., 2015). 
 
HEU infants have been reported to have increased opportunistic infections such as lower 
respiratory infection, pneumonia and gastroenteritis, with less successful outcomes to intervention 
and treatment by IV antibiotics during hospitalisation (Slogrove et al., 2012, 2016; Adler et al., 2015; 
Slogrove, Archary and Cotton, 2016, Passmore etal., 2017).  Previous studies revealed that HEU 
infants  have an altered innate and adaptive immune response, including  the natural killer and TH4 
memory cell functions  (Smith et al., 2017). This group of HEU infants present are thus an ever-
increasing and uniquely vulnerable population that may place an enormous burden on South 





Chapter 1. Literature Review  
1.1 The Microbiome  
According to Lederberg’s definition the microbiome is an “ecological system of commensal, symbiotic, and 
perhaps pathogenic microorganisms that reside in the human body”(Lederberg and McCray, 2001). Lederg 
popularised this term in 2001 and it has since been used frequently to describe the microbial composition of 
an environmental sample.  
Despite the technological advances in omics over the last decade which allows for an in-depth investigation 
of the microbiome, understanding the biological impact of the gut microbiome on disease remains in its 
infancy. Here the microbiome is defined as “a collection of an array of microorganisms their genes, genomes 
and metabolites, that have colonised the human body“ (Pflughoeft and Versalovic, 2012). A large proportion 
of these microorganisms form an integral part of the first line of defence but were  previously studied as 
pathogens believed  to be the cause of disease (Pallen, 2011). When the microbes are in a symbiotic 
relationship the body functions optimally, however a dysbiosis can result in alterations in normal bodily 
functions (Pflughoeft and Versalovic, 2012; Cerea et al., 2015). The microbiome has been linked to several 
disease states and the relationship between health and microbiome composition has recently been 
established as not only correlative but also causative (Turnbaugh et al., 2006a; Round and Mazmanian, 2009). 
Illnesses like Irritable Bowel Syndrome (IBS) as well as Crohns disease have all been linked to a dysbiosis in 
gut bacterial composition. The microbiome and its involvement in disease progression is still not well 
understood causing gaps in the knowledgebase. 
Background 
The microbial colonisation of the human has recently been shown to begin in utero (Jeurink et al., 2013). 
Until recently, it was thought that the infant developed in a sterile environment within the amniotic sac. 
However, new evidence suggests that the amniotic sac is not sterile, as  evidence of bacteria in the  
meconium of healthy new-borns  has been found (Jeurink et al., 2013; Aagaard et al., 2014; Wassenaar and 
Panigrahi, 2014; Perez-Muñoz et al., 2017).   Currently there is no consensus on the theory of a non-sterile 
womb. Recently, Rodriguez and colleagues investigated  the reagents that were used in the first study to 
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report the presence of microbes in the womb and the reagents  themselves could give rise to a DNA signal  
thought to be due to a contaminant, termed the “kit-ome”, that results in DNA signals being picked up (Leiby 
et al., 2018; Lim, Rodriguez and Holtz, 2018; Theis et al., 2019).  Salter and colleagues, highlighted the 
possibility of  DNA contamination of  samples with a low biomass by various sources such as  molecular 
biology grade water, PCR reagents and DNA extraction kits themselves (Salter et al., 2014).The argument in 
favour of the theory of a sterile womb is the successful delivery of germ free infants in several species 
including humans (Kirk, 2012; Leiby et al., 2018). It remains possible therefore that the DNA being recorded 
may just be contaminant DNA (Leon et al., 2018).  
During the birthing process, the mode of delivery influences the microbial colonisation and composition of 
the infant (Armanian et al., 2016).  Furthermore after birth the microbial colonisation of the infant gut 
continues and is influenced by mode of feeding (Armanian et al., 2016). The gastrointestinal tract is a large 
component of the human immune system (Wittig and Zeitz, 2003) and is considered as an extra organ. 
Therefore, its modulation can have a severe impact on disease progression and outcome (Kinross, Darzi and 
Nicholson, 2011). Several studies suggest that the human gut microbiome interacts with the human immune 
system and in turn influences immune function thereby affecting disease progression of many illnesses 
ranging from infectious diseases to non-communicable diseases (Turnbaugh et al. 2006b; Jeurink et al. 2013; 
Magne et al. 2017; Dietert 2017).  
The microbiome in healthy individuals 
The human microbiome project (HMP) was launched in 2007 with the aim of characterizing the microbial 
composition of a healthy human microbiota and help generate a better understanding the human microbe 
interactions (NIH HMP Working Group et al., 2009). Interestingly, the HMP has enabled the classification and 
investigation of the microbiomes of various sites on healthy individuals (Turnbaugh et al., 2007). The data 
collected revealed that the microbial population was inter and intra-variable suggesting that the microbial 
population varied among different habitats within the same host (Grice et al., 2009; Pallen, 2011). Further, 
the same habitats in different hosts have different microbial composition albeit each of the habitats had 
signature phyla present although in varying degrees (Costello et al., 2009; Grice et al., 2009; Caporaso et al., 
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2011; Ursell et al., 2012). Despite the taxonomical differences, signature bacterial species/phyla were 
associated with specific functional and metabolic pathways (Huttenhower et al., 2012). This suggests that a 
large microbial variation is to be expected within healthy controls. On the contrary, diseased conditions had 
a dysbiosis with very low microbial diversity as well as the presence of pathogenic bacteria (Li et al., 2016; 
Pammi et al., 2017).  Furthermore, no pathogenic species of bacteria were identified in any of the healthy 
individuals suggesting that the presence of a pathogenic bacteria (organism) could be associated with a 
disease state (Grice et al., 2009; Consortium et al., 2012). The inter-individual variation could be attributed 
to functional relevance within the host and the environment (Consortium et al., 2012). The HMP has defined 
the microbiome of a healthy individual as reference point when studying the microbiome and its dysbiosis. 
Recent findings have revealed that although taxonomical variation may exist the functional metabolic 
pathways that are presented remain broadly the same  (The Human Microbiome Consortium Project,2012).  
Various areas of the human body have been studied: the skin, mouth and the gut. Each of these areas 
possesses various microenvironments. The skin, the  organ most exposed to interaction with the 
environment and microbes (Fredricks, 2001; Kong et al., 2012), has different microenvironments with 
different microbiome compositions (Gao et al., 2007; Costello et al., 2009; Grice et al., 2009; Kong et al., 
2012). For example, the armpits are characteristically moist and dominated by Corynebacterium, whilst dry 
areas like the knees and elbows are  dominated by β-Proteobacteria and Flavobacteria (Grice et al., 2009).  
The oral microbiome which includes the mouth also has distinct areas such that the microbiome between 
the gums and the teeth is different to that found on the buccal cavity (Paster et al., 2006; Zaura et al., 2009; 
Dewhirst et al., 2010). Often the microbes such as Streptococcus, Fusobacterium, Actinomyces, Veillonella, 
and Treponema studied in the mouth have been associated with a pathogenesis (gum disease, tonsillitis and 
cavities) (Zaura et al., 2009). It has been known that the mouth harbours microbes, but only recently have 
“healthy” mouth microbes been discussed (Dewhirst et al., 2010). A 2009 study by Zaura et al. revealed the 
possibility of a core oral microbiome in healthy individuals. The study showed that there was a 72% overlap 
in the taxa of the microbes that were isolated from the three healthy Caucasian  male adults (Zaura et al., 
2009).  
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Whilst each area has a distinct microenvironment a pattern exists within each area that defines what a 
“healthy” microbiota is. For example, a healthy vaginal microbiome is characterised by low diversity with an 
abundance of Lactobacillus (Ling et al., 2010; Jacques Ravel, Gajer, Abdo, Schneider, Koenig, Stacey L 
McCulle, et al., 2011; Ma, Forney and Ravel, 2012). The composition of the vaginal microbiome has been 
profiled and arranged into five groups by abundance/dominance: group I is Lactobacillus crispatus dominant, 
with group II being Lactobacillus gasseri dominant, group III is Lactobacillus iners dominant and group V is 
Lactobacillus jensenii dominant. However group IV is a heterogeneous group of strict anaerobes (J. Ravel et 
al., 2011). Interestingly a low diversity was not always the case for a healthy vaginal microbiota, as 
differences in microbial composition have been found amongst women of different ethnic groups. Women 
with African-American ancestry have a more diverse bacterial composition compared to women with 
European ancestry (Jacques Ravel, Gajer, Abdo, Schneider, Koenig, S. L. McCulle, et al., 2011; Fettweis et al., 
2014).  
To date, the gut microbiome has been the most studied due to its size and impact on health. A dysbiosis in 
the gut microbiome has been associated with a range of ailments. Diseases such as diabetes, a metabolic 
dysbiosis, have been associated with the relative abundance of Firmicutes been found to be lower, whilst 
the proportion of Bacteroidetes and Proteobacteria was higher in diabetic persons compared to non-
diabetics (Larsen et al., 2010). The impact of the gut microbiome on inflammatory bowel diseases such as 
Crohn’s disease and ulcerative colitis has also been investigated. Cohn’s disease is characterised by chronic 
inflammation of the lining of the digestive tract which can lead to abdominal pain (Gevers et al., 2014). 
Recent studies have revealed a link between the disease states, host genetics, the gut microbiome and 
alterations in specific metabolomics pathways (Fung et al., 2012; Gevers et al., 2014). Studies of the intestinal 
gut microbiota imply that an unbalanced microbial community composition is associated with a dysregulated 
immune response, suggesting the role of the microbiome in pathogenesis (Fung et al., 2012). 
Studies based on Crohn,s disease phenotype showed a strong positive correlation with clinical disease 
severity and negative correlation with species richness. This suggests that a severe disease state manifests 
with severely reduced species diversity in favour of a dysbiosis (Gevers et al., 2014). The dominant species 
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in Crohn’s disease were Escherichia coli, Eikenella corrodens,Haemophilus parainfluenzae (Pasteurellaceae), 
, Fusobacterium nucleatum  Veillonella parvula, (Neisseriaceae) and Gemella moribillum (Huttenhower et al., 
2012; Morgan et al., 2012b; Sheehan and Shanahan, 2017). Whereas the  species that  decreased in Crohn’s 
disease were Bacteroides vulgatus, Bacteroides caccae, Bifidobacterium bifidum, Bifidobacterium longum, 
Bifidobacterium adolescentis, Bifidobacterium dentum, Blautia hansenii, Ruminococcus gnavus, Clostridium 
nexile, Faecalibacterium prausnitzii, Ruminoccus torques, Clostridium bolteae, Eubacterium rectale, 
Roseburia intestinalis, and Coprococcus  (Morgan et al., 2012a; Gevers et al., 2014). 
Interestingly, the microbial population showed less variety in the stool samples than in the mucosal tissue 
samples (Gevers et al., 2014; Slingerland et al., 2017). This highlights a disadvantage with using faecal 
samples for microbiome studies, however this sample type is the most easily, non-invasive retrievable 
sample type. 
The Microbiome in pregnant women 
Many changes occur in a woman’s physiology during pregnancy and lactation, which affect virtually all 
systems, including the cardiovascular, respiratory, genitourinary and digestive systems. Interestingly, such 
adaptations may favour an increased bacterial translocation during late pregnancy and early lactation (Figure 
1). The main effects of gestation on the digestive tract are associated with the displacement of the abdominal 
organs by the growing uterus, decreased motility and a large increase in the size and complexity of the 
maternal intestine (Jimenez et al ,2008). Overall, the digestive tract is characterized by weakened barriers 
against bacterial growth, increased permeability, and reduced peristalsis, these three factors that are closely 




Figure 1. Physiologic adaptations of the body during pregnancy that may favour an increased bacterial 
translocation (Rodríguez, 2014). 
 
 
There are several factors that influence the gut microbiome of the infant (Figure 2). Colonization of the infant 
gut begins in-utero and continues during birth. Babies delivered vaginally will have a gut microbiome similar 
to that of their mothers’ vaginal microbiomes including Lactobacillus and Bifidobacterium species (Kumar et 
al., 2016; Urbaniak et al., 2016), while those babies delivered by a caesarean will have a gut microbiome 
similar to the skin of their mothers, with lower numbers of Bifidobacteria and Bacteroides, and more often 
colonized with Clostridium difficile (C.difficile) compared with vaginally born infants (Dominguez-Bello et al., 
2010, 2013; Song, Dominguez-Bello and Knight, 2013). Infants born by elective caesarean delivery were 
shown to have a particularly low bacterial richness and diversity (Dominguez-Bello et al., 2013) . 
After birth, the mode of feeding further affects the infant gut microbiome composition (Le Huërou-Luron, 
Blat and Boudry, 2010; Fan et al., 2013; Mueller et al., 2015). Formula-fed infants have been shown to have 
a significantly different gut microbiome mainly dominated by Bifidobacterium fragilis (B. fragilis) compared 
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to breast-fed infants dominated by Bifidobacterium infantis (B.infantis) (Le Huërou-Luron, Blat and Boudry, 




Figure. 2. Factors influencing the colonization of the infant gut. Widely performed perinatal interventions 
such as mode of delivery, infant feeding practices, antibiotic usage and environment affect the colonization 
of the infant gut, Other factors such as maternal stress during pregnancy, gestational age, genetics, and 
infections (pre- and/or postnatal) also influence the microbial composition of the infant gut 
microbiota(Heijtz, 2016)  
 
1.2 Microbiome analysis tools 
Until recently microbiome studies focused on the microbial composition, with an emphasis on the bacterial 
component as methods have already been established to isolate and culture certain bacteria. The methods 
to study the microbiome have since expanded to include non-culture dependant methods. 
 
Culture dependent techniques  
The microbiota has been traditionally studied using culture-dependent techniques. This method is cheap, 
easy, quick and offered high taxonomical discrimination (Vaz-Moreira et al., 2011). It also gives information 
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on viability of the strains which culture-independent microbiological techniques do not. However, culture 
dependent techniques are limited as a large proportion of the organisms found in environmental samples 
are fastidious and do not thrive in culture (Jost et al., 2013). This led to the need to adopt different methods 
to analyse the microbiota in samples. 
 
Culture Independent Tools  
Metagenomics  
The recent advancement and development of genomic technologies has given rise to the ability to study the 
microbial profile in samples without the use of culture. Massively parallel sequencing, also called Next-
generation sequencing (NGS), targets the bacterial 16S rRNA gene allowing for an in-depth insight into the 
bacterial community. The 16S rRNA region in bacteria is ideal for this purpose, as it is a well conserved region 
of the bacterial genome that is able to provide species specific identification of bacteria due to its variable 
regions (De Filippo et al., 2010; Ghanbari, Kneifel and Domig, 2015). The use of NGS allows for the 
identification of fastidious microbes that do not thrive in culture. One of the objectives of the  MetaHIT 
(Metagenomics of the Human Intestinal Tract) project was to  compile a  human gut microbial catalogue 
using  metagenomic sequencing (Qin et al., 2010). This study revealed that the highest abundance of phyla 
observed were in Bacteroidetes and Firmicutes. The study also revealed clusters of bacteria at the genus 
/family levels. Bacteroidetes and Dorea/Eubacterium/Ruminococcus groups well as 
BIifidobacteria/Proteobacteria and streptococci/lactobacilli groups. These findings revealed that similar 
groups of bacteria may be shared amongst individuals (Qin et al., 2010; Morgan, Segata and Huttenhower, 
2013). 
However, this technique is not without its drawbacks, the most notorious being PCR bias (Xuan et al., 2013). 
The overall bacterial community representation may be skewed depending on the bias introduced using the 
species-specific primers. In addition, information on the viability of the bacterium is not provided (Xuan et 
al., 2013). Another shortcoming of metagenomic sequencing is depth bias, which is the inability to identify 
bacteria that are present in lower concentrations and taking into account the complexity of stool samples a 
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portion of  the population will remain unidentified (Lagier et al., 2015). Whilst the method was able to reveal 
a more complex microbial community it also highlighted that many of the microbiota found were 
unidentified and uncharacterised. This gave rise to the need for better culture techniques resulting in a 
technique called culturomics  
Culturomics 
Culturomics is the growing of different bacteria under different culture conditions, that mimic the 
environmental conditions from which the sample was collected (Greub, 2012b). The rise of culturomics was 
facilitated by the number of unknown bacteria that were identified using NGS. The use of microbial 
culturomics was first described by Lagier and colleagues in 2012 (Lagier et al., 2012, 2015). Culturomics made 
use of the advances made in mass spectrometry methods to rapidly identify bacterial colonies that were 
grown under different culture techniques. This method allowed for the identification of previously 
unidentified bacteria (Lagier et al. 2015; Greub 2012; Fournier et al. 2015). 
Whilst this technique does have its advantages, the biggest problem with culturomics is the time-consuming 
process and how costly it is to setup each culture condition. However, the technique does allow for the 
verification and culturing of clinically relevant viable species identified.  
Importantly, the microbiome consists of not only microorganisms, but it also made up of proteins and 
metabolites that affect how the microorganisms within the environment interact with each other and those 
must be considered if we are to truly understand how the microbiome affects health. Today, mass 
spectrometry techniques allow identification of multiple components of the microbiome. 
Mass spectrometry-based methods for microbiome /omics   
A mass spectrometer is an instrument that is used to measure the mass to charge ratio of a molecule. Mass 
spectrometry is a technique where the compounds are ionized into charged molecules, these ions are 
fragmented  and the ratio of their mass to charge (m/z) is measured (Hoffmann and Stroobant, 2007; Singhal 
et al., 2015). It consists of three parts:  
(i)an ion source that functions to charge the molecules into a gas phase  
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(ii) a mass analyser that functions to evaluate the mass-to-charge(m/z) ratio of the charged ions 
passing through the mass spectrometer and  
(iii) a mass detector that measures the number of ions at each m/z value and generates a spectrum 
as an output.  
A variety of ionisation techniques are used for mass spectrometry, the most preferred method for 
proteomics being electrospray ionisation (ESI) (Griffiths and Wang, 2009). ESI relies on the formation of gas 
phase ions from analytes in a liquid solution. The solution is propelled through a capillary by an electrical 
field, evaporated and charge is transferred to the analyte, thereby creating gaseous ions (Di Falco, 2018). 
The ionisation of compounds is not completely understood and two theories have arisen to try and explain 
the ESI process: the ion evaporation model (IEM) and the charge residue model (CRM) (Hoffmann and 
Stroobant, 2007; Mandal et al., 2013). 
In a Time-of-flight (TOF) analyser the ions are accelerated by an electric field into the analyser and the time 
taken for the ions to drift through a field-free chamber to reach the detector is then measured. The time 
taken is used to infer the ions m/z ratio (Peng et al., 2003; Di Falco, 2018). 
 
 
Figure 3: Schematic diagram of the Q-exactive Mass spectrometer 
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Most “-omic“ experiments are conducted on tandem mass spectrometers (Griffiths and Wang, 2009). 
Tandem mass spectrometers are MS/MS analysers. Initially a peptide ion is detected and selected for 
fragmentation within the mass spectrometer (MS) (Di Falco, 2018). This generates an m/z ratio of the parent 
ion as well as an m/z ratio of its fragment ions. The most common type of fragmentation is collision-induced 
dissociation (CID) (Gundry et al., 2010). 
Mass spectrometry coupled technologies can be applied to a wide range of “omics “studies: proteomics, 
lipidomics and metabolomics. The ability for a single instrument to be applied to various sample types has 
mass spectrometry at the forefront of microbiome studies. This has already been applied to a field like 
culturomics. The use of mass spectrometry allowed for the identification of previously unidentifiable bacteria 
(Lagier et al. 2015; Greub 2012; Fournier et al. 2015) 
Proteomics-based mass spectrometry  
This then brings us to the application of mass spectrometry for proteomic analysis. Proteomics is defined by 
Patterson and Aebersold as “the systematic study of the many and diverse properties of proteins in a parallel 
manner with the aim of providing detailed descriptions of the structure, function and control of biological 
systems in health and disease” (Patterson and Aebersold, 2003). MS methods for protein identification have 
evolved as better techniques and technologies have arisen. At the onset of MS coupled proteomics, various 
workflows were used to separate proteins. Initially, use of MS techniques in proteomics relied on the use of 
gel separations such as sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS PAGE) extractions. 
SDS PAGE was extensively used at the onset of proteomic studies, however it was prone to sample loss and 
it suffered from low resolution (Thelen and Peck, 2007). This necessitated the use of alternative technique 
for protein separation giving rise to the use of the mass spectrometer coupled to chromatographic 
separation techniques for proteomics. The method allows for better identification of proteins in complex 
protein mixtures. This resulted in improved separation and identification of proteins. 
The most popular coupled mass spectrometry technique for proteomics is Liquid Chromatography (LC) 
MS/MS, also known as shotgun proteomics (Di Falco, 2018). Typically, samples are prepared in a bottom up 
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or top down manner. Top down proteomics aims to characterise proteins by ionizing and dissociating an 
intact protein (McLafferty et al., 2007), whereas bottom up proteomics relies on the digestion of a complex 
protein mixture by a protease – usually trypsin - to form peptides (Aguilar, 2004; Gundry et al., 2009). The 
peptide mixture is then separated by online chromatography coupled to an ESI and analysed by MS/MS 
(Patterson and Aebersold, 2003; Aguilar, 2004; Gundry et al., 2010). The generated spectra are searched 
against a database for the identification of proteins from the peptide sequences. The need for of a well 
curated database for spectral matching as well as the presence of a unique peptide as an identifier for 
positive protein identification is a challenge facing proteomics in the microbiome field.  
MALDI-TOF identification of bacterial isolates grown in culture 
Once cultured, bacterial isolates can be identified using MALDI-TOF (Matrix Assisted Laser Desorption 
Ionization-Time of Flight) mass-spectrometry (Clark et al., 2013; Singhal et al., 2015). The compound to be 
analysed is dissolved in a solvent, called the matrix (Hoffmann and Stroobant, 2007). The analyte is 
embedded in the matrix prior to irradiation by a laser. The irradiation results in the ionisation of the analyte 
and these ions are accelerated by an electrostatic field towards the analyser (Dingle and Butler-Wu, 2013). 
The detector measures the m/z ratio and generates spectra. The Bruker ‘Biotyper’ system relies on the 
unique ribosomal protein signatures generated by different species of bacteria. An m/z spectrum is 
generated, and the spectra are matched to those in the Bruker database. A score is assigned as to how 
accurately the microbe was identified (TeKippe et al., 2013). MALDI-TOF is affordable, quick and accurate, 
but is limited by the availability of a reference spectra for the successful identification of the bacterial isolate. 
It also relies on culture techniques and some bacteria do not thrive in culture (Singhal et al., 2015).  
Metaproteomics   
Whilst metagenomic approaches have allowed for the identification of bacterial species that do not thrive in 
culture, it does not reflect the functional proteins expressed within the microbiome. Metaproteomics is a 
field of study that is concerned with identifying proteins within an environmental sample. This sample type 
is more complex than those investigated by regular proteomics. As previously described the microbiome 
consists not only of bacterial components (although these have been the most well defined and studied) it 
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also includes metabolites and proteins from non -bacterial sources. Metaproteomics in the microbiome 
space allows for the identification of bacterial contributions as well as the identification of other microbial 
components such as viruses, fungi and even human/host effectors. The biggest challenge facing the use of 
MS for microbiome studies is the lack of an agreed upon protocol. As this type of an experiment would 
generate a large amount of data, further downstream bioinformatic processes are also required. 
 
Table 1. Table of different methods applied to microbiome studies. 




Fastidious organisms do not thrive  
Time consuming  
Expensive  
Metagenomics Quick  
Easy  
Data analysis tools for downstream 
analysis readily available.  
PCR primer bias  
Does not infer viability 
Skewed towards only bacterial 
components 
Metaproteomics Quick  
Easy  
Identify all proteins: greater coverage  
Preparation sample loss 
Identification relies on well curated 
database  
Most abundant proteins mask the less 
abundant proteins  
Data analysis tools for downstream 
analysis not readily available. 
Standardised sample preparation 
protocol doesn’t exist. 
 Culturomics  Fastidious organisms grown  
Ability to identify new organisms 
Expensive  
Time consuming  




The profile of the gut microbiome in HIV-exposed uninfected infants in Africa will be different from 
that of HIV -Unexposed infants and this difference may contribute to altered immune responses  
 
Aims and Objectives: 
1.Elucidate the gut microbiota in HIV- exposed uninfected infants using liquid chromatography mass 
spectrometry (LC-MS) 
2. Use LC-MS to identify bacterial effectors (proteins) which potentially mediate the interaction 




Chapter 2. Methodology  
The South African infant mother cohort was recruited from Khayelitsha, an urban township with a high 
prevalence of unemployment and informal housing that is located 35km from Cape Town. Khayelitsha has a 
high prevalence of HIV positive mothers who are on ARV treatment. The Mother and infant pairs were 
enrolled at the Maternal Obstetric Unit (MOU) at Site B, the largest of two public sector delivery units that 
serve the estimated 400,000 living in Khayelitsha.An estimated 30-32% of the deliveries are to HIV-infected 
mothers. Unemployment and informal housing are highly prevalent in the area . (Appendix A.1). Stool was 
collected from the infant’s nappy at birth and day 4-7, placed in stool specimen containers. The samples 
were   stored at -80 0 C till sample preparation. 
 
2.1 Selection Criteria and ethical considerations 
This was a study, nested within a previously approved study: Innate, Adaptive and Mucosal Immune 
Responses in HIV-1 Exposed Uninfected Infants: A Human Model to Understand Correlates of Immune 
Protection with HREC/REF:285/2012, referred to as the “InFANT study” seeks to identify correlates of 
protection against HIV conferred by exclusive breast feeding.. The parent study has approved informed 
consent documents that are currently in use. In addition, details regarding the participants, inclusion and 
exclusion criteria, data confidentiality, ethical considerations and risks to and benefits for participants are 
described in the parent study HREC/REF: 285/2012. This sub study has ethics approval to carry out 
metaproteomic work on a subset of the infant’s stool samples: HREC 062/2018 (Appendix A.2). 
For this study, we analyzed existing stool samples stored from the InFANT cohort to characterize the infant 
gut proteome and metabolome of 34 HIV exposed uninfected (HEU) versus 29 HIV-unexposed (HU) infants, 
from the South African arm of the study, during the first week after birth in breastfed infants. The cross-





Table 2. Eligibility criteria for sample recruitment in InFANt Study 
 
HIV exposed cohort  HIV unexposed cohort 
1) Mother is HIV infected 
 
1) Mother is HIV uninfected  
2) Age of mother ≥ 18 yrs. 
 
2) Age of mother ≥ 18 yrs. 
 
3) Mother has self-chosen to breast 
feed her infant 
 
3) Mother has self-chosen to breast 
feed her infant 
 
4) Mother is able and willing to do the 
follow up  
assessments and provide informed 
consent 
4) Mother is able and willing to do the 
follow up  








1) Gestational age ≥35 weeks 
 
1) Gestational age ≥35 weeks 
 
2) Birth weight ≥ 2.0kg 
 
2) Birth weight ≥ 2.0kg 
 
 
Exclusion criteria  
 
Maternal Factors: Complications during pregnancy and delivery such as chorioamnionitis 






Table 3. Clinical information of infant mother diads recruited for study. 
 
Status  HEU HUU 
Timepoint  Birth  D4-7 Birth  D4-7 
Female infants  10 8 2 11 
Male infants  3 13 5 11 
Average infants birth weight (g) 3184,6 3051,4 3251,4 3082,7 
Average infants birth height 
(cm) 
48,2 47,8 49,4 46,8 
Average infants head 
circumference (cm) 
33,5 32,7 34,4 33,3 
Average infants temperature 
(celsius) 
36,4 36,6 36,6 36,5 
Average Infants gestational age 
in weeks 
39 38 38 39 
Infants on Arv Yes Yes N/A N/A 
Average Mothers CD4 count  427 463 N/A N/A 







Figure 4: Flowchart of the workflow followed for sample processing and analysis  
 
2.2 Stool homogenization and Protein Extraction   
Each stool sample was handled independently and snap frozen using liquid nitrogen and homogenized 
mechanically to a fine powder by use of a pestle and mortar. Once homogenized the powder was placed in 
amber glass vials and isopropanol added. The samples were incubated over night for 18 hours in a fridge at 
-20o C. The stool was further homogenized, and cells disrupted by sonication at maximum power for six cycles 
of 45 seconds with 1-minute cooling on ice between cycles (Rezwan et al ,2007). The tubes were centrifuged 
at 3500 rpm for 30 minutes and the supernatant was removed and placed in amber glass vials for storage at 
-80o C. Supernatant was removed from the pellet and stored in a separate glass vials after each centrifugation 
steps during the sample preparation. The supernatant was stored for future metabolomics study but not 
analyzed as part of this study. The pellet was then resuspended in a 1:1 (v: v) chloroform-methanol solvent 
and vortexed for a minute prior to 18-hour incubation at -20oC. After incubation, the chloroform-methanol 
resuspension was centrifuged at 3200rpm for 30 minutes. The pellet was then resuspended in a 100% 
methanol and centrifuged at 3400 rpm for 30 minutes at 4oC. The supernatant was decanted off and the 
tubes were air dried, after which the pellet was resuspended in Denaturation Buffer (10mM Tris-HCL, 6M 
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urea, 2M thiourea, pH8) and stored at -20oC for downstream protein digestion and mass spectrometry 
analysis. 
 
2.3 Protein quantification and Digestion  
A modified Bradford assay (Ramagli, 1999), using 1% HCl solution, Bradford Reagent and Bovine Serum 
Albumin (BSA) as a standard, was carried out to quantify the amount of protein in each sample. Total protein 
was calculated and 200µg of proteins were aliquoted out and reduced in 1µL of 1M DTT for 1 hour followed 
by incubation in 1µL of 550mM iodoacetamide (IAA) for another hour. The samples were diluted four-fold in 
20mM ABC pH 8 prior to trypsination, with sequence grade modified trypsin (Promega, Madison, USA) added 
at a 1:50 (w/w) ratio, 2M CaCl2 was added to the vials at a 1:10(v/v) ratio. The vials were wrapped in foil and 
incubated for 16 hours on a shaker at medium speed. Trypsination was ended by addition 1µL of 100% Formic 
acid. 
 
2.4 Desalting and purification  
10 µg aliquots of the resulting tryptic peptides were desalted using in-house produced C18 stage tips. 
Activation of the C18 discs was carried out by three rinses with 80% acetonitrile (ACN), followed by three 
rinses with 2% ACN. 10µg of each sample was added to the C18 discs, one sample per stage tip, and 
centrifuged. The sample were desalted by three rinses of 2% ACN followed by elution into glass capillary 
tubes by three rounds of 100µL of 60% ACN, 0.1% formic acid. The activation, equilibration, peptide wash 
and elution were carried out at 4000rpm for 5 minutes each rinse. The samples were dried in a vacuum 
concentrator Speedy Vac at 30 0 C for 45 minutes and reconstituted in 40µL of 2% ACN, 0.1% formic acid to 
250ng/µL solution, prior to LC-MS/MS analysis.A pooled sample of  1µL from each of the reconstituted 
samples  was also prepared  prior to LC-MS/MS analysis  
 
2.5 Liquid Chromatography-Mass Spectrometer analysis 
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Samples were analysed on a Thermo Scientific Dionex Ultimate 3000 UHPLC (Thermo Fisher Scientific, 
Waltham, MA, USA) coupled to a Thermo Scientific Q-Exactive hybrid quadrupole orbitrap mass 
spectrometer. The samples were loaded onto a 2 cm Luna C18 100 µM internal diameter fused silica trap, 
packed in-house, and then separated on a 30 cm Aeris peptide C18 75 µM internal diameter analytical 
column, packed in-house and maintained at 40oC. The samples were randomised and run individually, and 
injection volumes were optimised batch-wise. All samples were eluted on a 70-minute gradient, with a 
constant flow rate of 300nl/min. Solvent A (0.1% Formic acid/ HPLC grade water) and solvent B (0.1% Formic 
Acid/ Acetonitrile). The gradient consisted of 2% solvent B for 10 minutes then increasing to 6% B for 2 
minutes, followed by increasing to 40% B at 40 minutes; followed by washing with 80% after 40 minutes and 
a 20-minute calibration, with a 45-minute wash between every 4 samples. 
Mass spectrometric analysis was facilitated by Xcalibur software (Thermo Scientific). The acquisition 
parameters were optimised in-house based on the settings described by (Pirmoradian et al, 2013) with a few 
amendments:. A top 10, data dependent, positive ion mode was used to acquire mass spectra with automatic 
cycling between MS and MS/MS scans as previously described by (Domon & Aebersold 2010). Ion 
fragmentation was performed by higher energy collision induced dissociation (HCD). MS1 settings included 
a resolution of 70000, scan range of 300-1750 m/z automatic gain control (AGC) target of 3E6, and an ion 
injection time of 250 ms. At the MS2 level the setting were as follows: isolation window of 4.0 m/z, a 
normalised collision energy (NCE) 25, resolution of 17500, AGC target of 5E4 and ion injection time of 80 ms. 
Data dependent settings included an underfill ratio of 1% (which equates to an intensity threshold of 
1.7x104), peptide match set to “preferred, isotopic exclusion, and a dynamic exclusion of 30 s. Charge 
exclusion was set to all unassigned charges, as well as all charges other than 2 or 3. 
 
 
2.6 Data Analysis  
The raw mass spectra were converted to Mascot generic files (mgf) format on MS convert. The mgf files were 
processed using an inhouse developed metaproteomic analysis pipeline, MetaNovo (Potgieter et al., 2019). 
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Briefly, de novo sequence tags were derived from the MS/MS spectra using DeNovoGUI version 1.15.11 
(Muth et al., 2014), with DirecTag (Tabb et al., 2008). The resultant sequence tags were mapped to the entire 
UniProt database (ca. 120m sequences) using a high performance and parallelized computing pipeline, 
generating compact databases for downstream target-decoy analysis and False Discovery Rate (FDR) 
controlled protein identification.  The output protein IDs from the initial MetaNovo search were then re-
searched with the original raw MS/MS dataset under stringent conditions using MaxQuant (v.1.5.5.0). 
The MetaNovo pipeline was used to generate a database with Fasta files from the raw files. MaxQuant 
version (1.5.3.12) software package was used to search the mgf file, using the Andromeda search engine, 
against the MetaNovo generated database. The default Maxquant settings were used with the following 
modifications: Trypsin was selected as an enzyme with a maximum of 2 missed cleavages, LFQ was selected 
for Label free quantitation, the default MaxQuant false discovery rate (FDR) cut-off of 0.01 (1%) was used at 
the peptide-spectrum level with use of a decoy database which included a nonsense reverse entry for every 
predicted protein. Protein identification was set at a minimum of two unique peptides required for protein 
identification. Match between runs was selected to increase identification of protein groups. Quantitation 
was via the MS1-based LFQ method embedded within MaxQuant All searches were performed on a virtual 
Windows server running on UCT High Performance Computer cluster (HPC). Statistical analysis was carried 
out in R to identify metaproteins that are differentially expressed between groups. 
MS data quality and identification summary statistics were assessed with the aid of a custom script in the R 
environment.  
 
2.7 Taxonomic analysis 
The taxonomical analysis was performed using the UniPept online software tool. Peptide sequences from 
the peptide.txt files for Birth and Day 4-7 were uploaded separately to the UniPept-web based platform with 
the following parameters: a) Equate I and L; b) Filter duplicate peptides and c) Advanced missed cleavage 
handling. The files were uploaded as separated by timepoint and exposed status.  
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2.8 Functional analysis  
Functional analysis of the taxa identified was carried out on the UniPept QuickGo plugin which generates Go 
Terms associated with proteins at the different Hierarchical level. The LCA level chosen was Chordata and 
Biological process was analysed.  
 
2.9 Protein analysis  
Proteingroups.txt file from the MetaNovo combined folder for each timepoint was uploaded onto Microsoft 
Excel, total number of peptides in each group were assessed and 2 or more peptides for positive protein 
identification was used. Each timepoint was analysed separately. Proteins were filtered for human only 
proteins and functional analysis of the proteins was executed on the Pantherdb.org web-based tool.  In 
Panther Gene List Analysis, the following parameters were selected: 1. ‘ID list’ selected as list type, 2. species 
set to Homo sapiens, and 3. Functional classification viewed on graphic charts. The Panther dB analysis was 
used to identify the protein classes identified in each group at both time points. 
 
Analysis of the protein groups was carried on Perseus 1.6.8.0. The proteinGroups.txt folder for Birth and 
Day4-7 were uploaded separately onto the Perseus platform, LFQ values were selected under the category 
of main. Rows were filtered based on categorical column, (Site, Reverse, and Contaminant). The rows were 
annotated categorically then checked for normal distribution, the rows were further filtered based on 
numerical /column, based on unique peptides with, >1 as the threshold. The data was then log transformed 
and rows filtered on valid values with a minimum of 2 in each group. A two-sample t test was carried out, 
with Benjamin-Hochberg FDR set for truncation and a volcano plot generated. Whilst there were no 
significantly upregulated proteins identified (p-value 0.05, FDR0.05) at either timepoint, some proteins were 
differentially expressed. 
A presence-absence analysis of the human proteins was carried out Proteingroups.txt file from the 
MetaNovo combined folder for each timepoint was uploaded onto Excel, total number of peptides in each 
group were assessed and 3 or more peptides for positive protein identification was used. Proteins were 
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filtered out for human only proteins. the human proteins were then uploaded onto Venny2.1.0 online 
platform to generate Venn diagrams and protein list exclusive to each group at each timepoint.  
 
From the presence-absence analysis proteins that were exclusively found in each sample set were uploaded 




Chapter 3: Results 
3.1 MS data quality  
During the sample preparation the concentration of the samples was measured using a modified Bradford 
assay. Once the concentration for each sample was determined the volume required for 200µL of protein 
was calculated and aliquoted into clean vials for Trypsin digestion. 
Table 4: BSA concentration of samples  
Sample ID  STATUS  Concentration (ug\uL) Timepoint  
4 HEU 3,75 Birth 
8 HEU 2,391 Birth 
9 HEU 4,103 D4-7 
10 HEU (-) D4-7 
11 HEU  (-) D4-7 
13 HEU  (-) D4-7 
16 HEU 3,56 D4-7 
17 HEU 8,61 D4-7 
18 HEU 5,452 D4-7 
20 HEU 0,183 Birth 
26 HEU 3,257 Birth 
38 HEU (-) D4-7 
54 HEU (-) Birth 
55 HEU (-) Birth 
61 HEU  (-) D4-7 
62 HEU 3,524 Birth 
63 HEU 1,111 Birth 
66 HEU 0,113   
71 HEU 0,939 Birth 
78 HEU  (-) D4-7 
81 HEU (-) Birth 
88 HEU 3,98 Birth 
92 HEU 1,562 D4-7 
100 HEU 5,77 Birth 
121 HEU 1,699 D4-7 
127 HEU 1,836 D4-7 
138 HEU  (-) D4-7 
140 HEU 5,61 D4-7 
142 HEU 6,34 D4-7 
143 HEU 0,34 D4-7 
156 HEU 6,589 D4-7 
157 HEU  (-) D4-7 
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159 HEU 4,69 D4-7 
161 HEU 2,15 D4-7 
302 HU 5,866 Birth 
305 HU (-) D4-7 
307 HU 3,404 Birth 
308 HU 5,188 D4-7 
309 HU 1,754 D4-7 
312 HU 1,73 D4-7 
314 HU 1,64 D4-7 
315 HU 7,83 D4-7 
316 HU  (-) D4-7 
318 HU  (-) D4-7 
319 HU 5,15 D4-7 
320 HU 1,83 D4-7 
325 HU 0,267 D4-7 
332 HU 3,027 D4-7 
337 HU 1,892 D4-7 
347 HU 1,304 D4-7 
345 HU didn’t process D4-7 
350 HU (-) D4-7 
354 HU 2,268 Birth 
357 HU 3,8 Birth 
359 HU 8,99 Birth 
360 HU 6,88 D4-7 
365 HU 8,48 Birth 
374 HU (-) Birth 
377 HU 3,98 D4-7 
381 HU 6,54 D4-7 
383 HU 7,86 D4-7 
387 HU 0,836 D4-7 
389 HU 2,91 D4-7 
 
The data analysis for the Birth and Day4-7 was carried out separately. MS1 and MS2 data were acquired for 
all samples on the LC-MS. 
For the Birth timepoint 13 HEU vs 7 HUU stool samples 1026286 spectra were submitted to MaxQuant 
software for analysis, 78320 (7.6%) were mapped to known tryptic peptide sequences in the MetaNovo 
generated protein database corresponding to an identification of 2816 protein groups and 10021 non- 
redundant peptides in total across the birth samples. Whilst the data had a good tryptic digest, with few 
missed cleavages, the data did have 4.9% contaminants present.  
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In the day 4-7 samples 21 HEU vs 22 HUU stool samples were processed, 828997 spectra were submitted to 
MaxQuant software and 68994 (8.3%) of the spectra were identified, corresponding with an identification of 
4712 protein groups and 16510 non redundant peptides were identified. The data had 2.5% contaminants, 
but the tryptic digestions were of good quality.  
An analysis of all the samples from both timepoints was also carried out. 2681796 spectra were submitted 
to MaxQuant software for analysis, 220488 (8.2%) of the spectra were mapped to known tryptic peptides in 
the MetaNovo generated database. This correspond to 5597 protein groups and 20864 identified peptides. 
The data generated was of good quality, with 0.8% contaminants identified in the protein groups. The 
number of identified peptide sequences varied amongst the samples and no batch effect was detected. Thus, 
all the samples could be analysed concurrently.  




Figure 5: Summary statistics generated on R  a) Bar graph of missed cleavages in the Birth samples  
generated from summary script in R displays the quality of the digestion of the trypsin, and indicates that 
the digestion of the protein into peptides was successful with 80.5% of the peptides identified revealing no 
missed cleavage .b) Bar graph of the missed cleavages in the Day4-7 batch of samples , the digestion of the 
protein into peptides was successful with only 80.2% missed cleavages .c)  Missed cleavages for all samples 
from both time points . 
The chromatograms generated had a good gradient and distribution over the duration of the run (refer to 
figure 6a). The reference sample and the pooled sample both show good charge and distribution (Appendix 
B.1) The pooled sample functions as quality control to aid in determining the optimum injection volume as 




Figure 6: Chromatograms generated from samples run on the Q-Exactive mass spectrometer a) reference 
sample SH-SY5Y, used to confirm the machine is running well 
b) pooled sample of stool sample used as an indicator of the optimum injection volume as well as assess if 
there is any contamination The injection volume was set to 2uL.  
 
 
3.2 Taxonomic identification 
Metaproteome analysis  
The Venn diagram reveals that there is some overlap in peptides that are identified within each group at 
each time point, however some peptides that are specific to each group have also been identified. Most of 
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the unique peptides were found in HEU at day 4-7 (20.6%), followed by HUU at day 4-7 (19.5%), HEU at birth 
(8.2%) and finally HUU at birth (7.3%). 
 
 
Figure:7: Venn diagram of the Peptides that are shared amongst the different groups at both timepoints. 
  
 
Figure 8: Bacterial metaproteome based on Phyla in the HEU vs HUU at Birth and during Day 4-7.   
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The difference in the relative abundance of the phyla at birth and at timepoint day 4-7 is depicted in Figure 
8. At Birth the microbiota of the HEU infant has more Bacteroidetes than HUU whereas at day 4-7 the HEU 
relative abundance of Bacteroidetes decrease and the relative abundance of Actinobacteria increases. There 
is a shift to a microbiome in the HEU that is dominated by Actinobacteria. Interestingly, the HUU birth 
microbiota has a greater abundance of Actinobacteria, however at day 4-7 the HUU is still dominated by 
Actinobacteria but the relative abundance is less than that observed in HEU infants.  
 
 
Figure 9: Stacked bar graph indicating the relative abundance of the metaproteomic classification based on 
Intensity of Class of bacteria in HEU and HUU infants at both time points  
 
 
The Class distribution of the microbiota belonging to the kingdom Bacteria 
At birth the HEU is and HUU are comprised of the same class of bacteria, however the relative abundance of 
each class in each group varies. In the HEU the majority is Bacteroidia, Actinobacteria, Gammaproteobacteria 
and Bacilli. Whereas in the HUU infant at birth has a microbiota comprised of mostly Gammaproteobacteria, 
Actinobacteria, Bacteroida and Bacilli respectively. The microbial composition of both the HEU and the HUU 
shift to an Actinobacteria dominated microbiota at day 4-7, with an increase in Coriobacteria in both infant 
groups (Table 5) .  
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Table 5: Numbers of peptides identified for each class 
Bacterial Class Number of peptides 
  D4-7HEU D4-7HUU Birth HEU Birth HUU 
Acidimicrobiia 1 1 0 1 
Acidobacteriia 1 1 0 0 
Actinobacteria 2565 1548 1812 429 
Alphaproteobacteria 18 17 11 7 
Anaerolineae 1 1 0 0 
Ardenticatenia 0 0 1 0 
Bacilli 247 142 27 59 
Bacteroidia 450 389 309 29 
Betaproteobacteria 25 15 17 4 
Candidatus Lambdaproteobacteria 1 1 0 0 
Chitinophagia 1 1 1 0 
Chlamydiia 0 1 0 0 
Clostridia 443 551 224 11 
Coriobacteriia 1198 707 2 9 
Cytophagia 5 4 2 2 
Deinococci 1 1 1 1 
Deltaproteobacteria 5 3 3 2 
Epsilonproteobacteria 2 3 1 0 
Erysipelotrichia 103 0 1 0 
Flavobacteriia 5 2 7 0 
Fusobacteriia 8 0 0 0 
Gammaproteobacteria 642 276 219 13 
Gemmatimonadetes 1 1 1 1 
Limnochordia 1 1 0 0 
Negativicutes 339 213 32 1 
Nitrospira 3 3 1 1 
Opitutae 0 1 0 0 
Phycisphaerae 3 3 0 0 
Planctomycetia 2 1 1 1 
Saprospiria 2 0 1 1 
Sphingobacteriia 4 1 1 0 
Spirochaetia 1 1 1 0 
Theionarchaea 0 0 1 0 
Thermotogae 1 1 1 1 
Tissierellia 1 0 1 1 
unassigned  2160 1401 837 134 
Verrucomicrobiae 0 0 1 1 
Zetaproteobacteria 1 0 0 0 
 
From the data generated it is observed that there is a difference in the composition of the class of bacteria 




Figure 10: Bacterial class abundance. 
 
The Contribution of each timepoint to each bacterial class is illustrated in Figure 10. The timepoint that has 
the greatest contribution to the bacterial classes is the D4-7HEU group. Some of the classes identified were 







































Bacterial Class abundance based on number of peptides identified 
D4-7HEU D4-7HUU Birth HEU Birth HUU
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attributed to one group only, Chlamydia and Opitutae were exclusively present in the D4-7HUU group whilst 
Theinoarchae and Ardenticatenia were only present in the Birth HEU group. Interestingly Erysipelotrichia 
was exclusive to the HEU groups at both time points. 
Birth HUU 
In the stool samples of the HUU infant at birth 4394 out of 4526 of the peptides uploaded onto UniPept were 
identified. Many of the peptide’s sequences, 74% in total, that were uploaded were mapped to Eukaryotes. 
Whereas only 16% of the peptides were mapped to the domain Bacteria. 
The bacterial composition of the HUU infant at birth is primarily composed of bacteria belonging to order 
Corynebacteriales, Bifidobacteriales and Lactobacteriales. All three of these orders have been previously 
identified in the faeces of humans. Of the Actinobacteria identified, the majority are mapped to peptides 
belonging to the family Bifidobacteriacea. The two species with the genus Bifidobacterium that were 





Figure 11: Sunburst chart generated on UniPept providing an overview of the organism identified HUU. 74% 
of the peptides identified belong to Eukaryotes Mesuere et al. (2015) 
Proteomics doi:10.1002/pmic.201400361 
 
The Bacteria in HUU at birth are not as abundant as in the HEU infant. Most of the peptides identified in the 





Figure 12: Expanded sunburst chart of the HUU microbiota at birth, detailing the bacteria identified, with 
16% of the peptides identified belonging to the bacteria superkingdom Mesuere et al. (2015) 
Proteomics doi:10.1002/pmic.201400361 
 







Figure 13: Treemap generated on UniPept of the organisms identified in HUU birth infants 
Mesuere et al. (2015) Proteomics doi:10.1002/pmic.201400361 
 
Birth HEU  
In the HEU birth infant’s UniPept analysis 7778 out of 8044 peptides were identified on the platform. In HEU 
infants only 44% of the peptides identified were matched to Eukaryotes, which suggests that the HEU 
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microbiome is more diverse than the HUU birth microbiome.  With 45% of the peptides identified belonging 
to the Kingdom bacteria, more than in the HUU birth samples 
 
Figure 14:Sunburst chart  generated on the UniPept platform providing an overview of the organism identified HEU 
birth, with 44%of the peptides identified belonging to Eukaryotes Mesuere et al. (2015) 
Proteomics doi:10.1002/pmic.201400361 
 
Within the bacteria superkingdom, many the peptides belonged to the order Bifidobacteriales, Bacteriodales 
(phylum Bacteroidetes) and Clostidiales (Phylum Firmicutes) Fewer Lactobacillales peptides were identified 
than in the HUU peers at birth. The species identified belonging to the genus Bifidobacterium were B. 






Figure  15:Expanded sunburst chart of the HEU birth microbiota , detailed on the bacteria ,45% of the 





Figure 16: Tree map  generated on UniPept platform of the organism present in the HEU-birth infants 
Mesuere et al. (2015) Proteomics doi:10.1002/pmic.201400361 
Day 4-7 HUU 
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At day 4-7 the microbiome of the HUU infant is more diverse with a decrease in the number of peptides 
matched to Eukaryotes down to 37 % and an increase in the number of peptides matched to the Bacteria 
kingdom up to 54%. This change in the composition suggests that the microbiome of the HUU infant is 
primarily colonised after birth. 
 
Figure 17: Sunburst chart providing an overview of the organisms identified in HUU D4-7 infants  , with 37.% 
of the peptides identified belonging to Eukaryotes Mesuere et al. (2015) 
Proteomics doi:10.1002/pmic.201400361 
 
The domain Bacteria is a large contributor to the infant microbiome Figure17 
A large portion of the bacteria identified belonged to the class Actinobacteria. The largest contributor to this 




Figure 18: Expanded sunburst chart of the HUUD4-7, with details on the bacteria. 54% of the peptides 





The HUU microbiota is also more diverse than at birth, with the major contributors to the bacteria belonging 
to the Phyla Actinobacteria, Firmicutes and Proteobacteria. However the majority of the peptides identified 
belong to the order Bifidobacteriales , with an increase in the number of Bifidobacterium species from two 
as at birth to twelve species : B. adolescentis, B. asteroides , B. bifidum, B. bohemicum, B. breve, B. callitrichos, 
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B. longum with subspecies B. longum, B.infantis B. mongoliense, B. pseudocatenulatum., B. 
psychraaerophilum, B. huminantium and B. scardovii 
Figure19:Treeview of the organism identified in HUU d4-7.Mesuere et al. (2015) 
Proteomics doi:10.1002/pmic.201400361 
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Day4-7 HEU  
At Day 4-7 in the HEU most peptides identified map to the kingdom bacteria, with only 27% of the peptides 
identified belonging to Eukaryotes. 61% of the peptides identified are bacterial derived and of that 61% the 
majority belong to the following phyla: Actinobacteria, Firmicutes and Proteobacteria. 
 
Figure 20: Sunburst chart providing an overview of the organism identified in the HEU. D4-7, 27% of peptides 
identified belonged to Eukaryotes Mesuere et al. (2015) Proteomics doi:10.1002/pmic.201400361 
 
As with the previous groups many peptides identified belonged to the genus Bifidobacterium with the 
following species identified:  B. bifidum, B. bohemicum, B. breve, B. callitrichos, B. catenulatum, B. commune, 
B kashiwanohense. B. longum, B. psuedocatenulatum, B. psychraerophilum and B. huminatium.. Interestingly 
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Figure 21: Expanded sunburst chart of the HEUD4-7 microbiota  , having details on the bacteria, with 61% of 












Table 6 Number of peptides identified that are associated with Mycobacterium Tuberculosis  
 
Sample  Group  Number of peptide sequences associated with mycobacterium tuberculosis  
Birth HEU 0 
Birth HUU 111 
Day4-7 HEU 54 
Day4-7 HUU 0 
 
 
The following phylum that are associated with parasitic infections were also identified. Platyhelminthes, 
Mollusca, Nematoda and Cnidaria . 
 
Table 7: Parasitic phyla identified  
Phylum  Number of peptide sequences identified   
  Birth HEU  Birth HUU D4-7HEU D4-7HUU 
Platyhelminthes  2 3 3 4 
Mollusca 3 1 3 2 
Nematoda 6 1 6 7 






Figure 23: A PCA plot of how the samples cluster according to the phyla present within both groups at each 
timepoint. The PCA plot demonstrates the overlap in the samples, with the largest overlap occurring 
between the HEU birth and Day 4-7 HUU infants. 
 
The overlap between the phyla present in the HEU and HUU infants at both time points reveals that the 
samples overlap greatest based on the timepoint and not on exposure status. The PCA also reveals that the 






Figure 24: Hierarchical cluster chart of all the expressed classes of organisms in the HEU and HUU at birth  
 
The hierarchical cluster chart at birth is based on the intensity of the peptides that were used to identify the 
class of organisms. From Figure 24 it is evident that there are a large number of classes, and interestingly the 
HEU and HUU samples do not cluster according to exposure state. This reiterates the interindividual 
microbiota of each infant as well as reaffirms the diversity within each sample. The HEU samples tend to 
cluster a bit more than the HUU samples.  




Figure 25: Hierarchical cluster chart of all the expressed classes of organism in HEU and HUU at day 4-7. 
 
Whereas the Cluster map for the samples at day 4-7 reveals a large increase in the number of expressed 
classes it also reveals greater variation in the how the samples cluster. At day 4-7 the demarcation between 
the samples is more complex. The intensity of the signals is also not as strong as it is at birth, which may be 




3.3 Functional Analysis of metaproteomic data: 
UniPept pathway analysis  
Biological processes 
The GO terms associated with the Chordata peptides were analysed on UniPept using the QuickGO plugin. 
Most of the peptides in the HEU at birth were associated with neutrophil degranulation, innate immune 
response and immune responses whereas in the HUU at birth the most abundant peptides matched to 
neutrophil degranulation, proteolysis and innate immune response. 
 
Table 8 3: Top 10 Biological process for Chordata peptides identified on UniPept online in HEU 
birth. 
Peptides GO term Name 
341 GO:0043312 neutrophil degranulation 
204 GO:0045087 innate immune response 
197 GO:0006955 immune response 
191 GO:0018149 peptide cross-linking 
191 GO:0006958 complement activation, classical pathway 
178 GO:0070268 Cornification 
168 GO:0006508 Proteolysis 
152 GO:0031424 Keratinization 
148 GO:0042742 defense response to bacterium 






Table 9: Top 10 Biological processes for Chordata peptides identified on UniPept online HUU 
birth.  
Peptides GO term Name 
249 GO:0043312 neutrophil degranulation 
151 GO:0006508 Proteolysis 
124 GO:0045087 innate immune response 
119 GO:0018149 peptide cross-linking 
115 GO:0006955 immune response 
112 GO:0005975 carbohydrate metabolic process 
110 GO:0030855 epithelial cell differentiation 
105 GO:0031424 Keratinization 
103 GO:0006958 complement activation, classical pathway 
103 GO:0043066 negative regulation of apoptotic process 
 
At day 4-7 the peptides matched to neutrophil degranulation, innate immune response and immune 
response in the HEU infant whereas in the HUU infant the top peptides matched to the carbohydrate 
metabolism, translation and glycolytic process.  
 
Table 10: Top 10 Biological processes for Chordata peptides identified on UniPept online HEU 
day 4-7 
Peptides GO term Name 
322 GO:0043312 neutrophil degranulation 
264 GO:0045087 innate immune response 
253 GO:0006955 immune response 
248 GO:0006958 complement activation, classical pathway 
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193 GO:0006911 phagocytosis, engulfment 
189 GO:0042742 defense response to bacterium 
168 GO:0005975 carbohydrate metabolic process 
168 GO:0019731 antibacterial humoral response 
167 GO:0006508 Proteolysis 
163 GO:0050900 leukocyte migration 
 
Table 11: Top 10 Biological processes for Chordata peptides identified on UniPept online HUU 
day 4-7. 
Peptides GO term Name 
526 GO:0005975 carbohydrate metabolic process 
483 GO:0006412 Translation 
308 GO:0006096 glycolytic process 
203 GO:0008152 metabolic process 
176 GO:0006094 Gluconeogenesis 
120 GO:0055085 transmembrane transport 
111 GO:0006006 glucose metabolic process 
104 GO:0006520 cellular amino acid metabolic process 
90 GO:0006457 protein folding 







3.4 Protein analysis results  
Pantherdb analysis  
Further pathway analysis was carried out on the Pantherid, using the protein-level identifications. The 
proteinGroups.txt file for each of the groups at each time point was analysed and all non-
human/Homosapien proteins were filtered out 
The most abundant protein class in all the groups at both time points was hydrolase, followed by enzyme 
modulator/immunity proteins. 
 
Figure 26: All protein classes identified in the Birth HEU infant group  
The top protein classes identified in the Birth HEU group were hydrolases, enzyme modulator and defence/ 
immunity protein. The defence /immunity protein class is within the top three classes of protein identified 
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by Panther dB in the Birth HEU group.  Whereas the defence /immunity protein class is the fourth most 
abundant protein class in the Birth HUU group  
 
Table 12: Top 10 protein classes identified for Birth HEU infant group  





Percent of gene hit 
against total # genes 
 Percent of gene hit against total 
# Protein Class hits 
hydrolase (PC00121) 35 18.1% 26.9% 
enzyme modulator 
(PC00095) 
21 10.9% 16.2% 
defense/immunity 
protein (PC00090) 
11 5.7% 8.5% 
signaling molecule 
(PC00207) 
9 4.7% 6.9% 
transferase (PC00220) 7 3.6% 5.4% 
cytoskeletal protein 
(PC00085) 
6 3.1% 4.6% 
oxidoreductase 
(PC00176) 
6 3.1% 4.6% 
calcium-binding protein 
(PC00060) 
6 3.1% 4.6% 
transporter (PC00227) 4 2.1% 3.1% 
storage protein 
(PC00210) 






Figure 27 : All protein classes identified for Birth HUU infant group 
 
Table 13: Top 10 protein classes identified for  Birth HUU infant group  





Percent of gene hit 
against total # genes 
 Percent of gene hit against total 
# Protein Class hits 
hydrolase (PC00121) 35 17.9% 23.6% 
enzyme modulator 
(PC00095) 
25 12.8% 16.9% 
oxidoreductase 
(PC00176) 
10 5.1% 6.8% 
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10 5.1% 6.8% 
cytoskeletal protein 
(PC00085) 
8 4.1% 5.4% 
transferase (PC00220) 8 4.1% 5.4% 
signaling molecule 
(PC00207) 
8 4.1% 5.4% 
transporter (PC00227) 7 3.6% 4.7% 
calcium-binding protein 
(PC00060) 
6 3.1% 4.1% 
lyase (PC00144) 4 2.1% 2.7% 
 
At the Day4-7 timepoint the most abundant protein classes for both the HEU and HUU are the same . With 





Figure 28: All protein classes identified for Day 4-7 HEU infant group 
 
Table 14: Top10 Protein Classes identified Day4-7_HEU 





Percent of gene hit 
against total # genes 
 Percent of gene hit against total 
# Protein Class hits 
hydrolase (PC00121) 32 20.6% 31.7% 
enzyme modulator 
(PC00095) 
16 10.3% 15.8% 
defense/immunity 
protein (PC00090) 
9 5.8% 8.9% 
signaling molecule 
(PC00207) 
7 4.5% 6.9% 
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6 3.9% 5.9% 
transporter (PC00227) 5 3.2% 5.0% 
cytoskeletal protein 
(PC00085) 
4 2.6% 4.0% 
oxidoreductase 
(PC00176) 
4 2.6% 4.0% 
transferase (PC00220) 3 1.9% 3.0% 
transfer/carrier protein 
(PC00219) 
3 1.9% 3.0% 
 
 
Figure 29: All protein classes identified for Day 4-7 HUU infant group   
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Table 15: Top 10  protein class identified Day4-7 HUU 





Percent of gene hit 
against total # genes 
 Percent of gene hit against total 
# Protein Class hits 
hydrolase (PC00121) 34 19.7% 28.3% 
enzyme modulator 
(PC00095) 
15 8.7% 12.5% 
defense/immunity 
protein (PC00090) 
11 6.4% 9.2% 
oxidoreductase 
(PC00176) 
10 5.8% 8.3% 
signaling molecule 
(PC00207) 
8 4.6% 6.7% 
transferase (PC00220) 6 3.5% 5.0% 
transporter (PC00227) 5 2.9% 4.2% 
calcium-binding protein 
(PC00060) 
5 2.9% 4.2% 
cytoskeletal protein 
(PC00085) 
4 2.3% 3.3% 
 
 
Volcano plots (Figure30) for proteins identified were generated on the Perseus platform; no significantly 
expressed proteins were identified in either one the groups, at each timepoint after multiple testing 
correction – likely reflecting the relatively high variability between metaproteomes from different individuals 
within each group and the relatively small number of samples per group. Thus a presence-absence analysis 








Protein presence absences analysis  
A presence-absence analysis was carried out on the proteins that were identified from the ProteinGroups.txt 
file, on the Venny 2.0 web-based platform. 
A total of 577 Human proteins were identified at the Birth timepoint: 361 (62.6%) of the proteins identified 
were shared by both the HEU and HUU infants at birth; 99 ( 17.2%) were exclusively found in the Birth HEU 
group; and 117 (20.3%) were exclusively found in the Birth HUU group. A total of 560 human proteins were 
identified in the Day 4-7 group. Of the proteins identified, 402 (71.8%) were shared amongst the HEU and 
HUU infants, with 104 (18.6%) of the proteins identified exclusively found in the HUU group and 54 (9.6%) 














Figure 31: Venn diagram of the protein groups that overlap at the different timepoints (a) Birth timepoint (b) 





Figure 32: Venn diagram of all the Human proteins shared in HEU and HUU at both the Birth and Day 4-7 
timepoint. (Oliveros, J.C. (2007-2015) Venny. An interactive toolfor comparing lists 
withVenn'sdiagrams. https://bioinfogp.cnb.csic.es/tools/venny/index.htm) 
 
Combined Venn diagram was generated of all the Human proteins identified .183 (21.7%) of the proteins 
uploaded were common in both HEU and HUU groups at both time points. 97 (11.5%) were exclusive to the 
Birth HUU and 35 (4.1%)) were exclusive to Birth HEU. Whereas 33 (3.9%) were exclusive to the Day4-7 HEU 
and 61 ( 7.2%) were exclusive to the Day4-7 HUU .  
From the data generated in the Venn diagram the human proteins that were exclusively found in each group 
at each timepoint was uploaded into String online platform, to identify the top biological processes. At birth 
HEU 21 of the 35 proteins were identified, For Birth HUU 56 of 97 proteins were identified.  Day4-7_HEU 8 




Table 16: Top 3Go enrichment Biological process exclusive Birth HEU 









6 485 0.0071 
GO:0043588 skin development 4 373 0.0244 
GO:0008544 epidermis 
development 
4 403 0.0294 
 
Table 17: Top 10 Go enrichment Biological process exclusive to Birth HUU 






















































Table 18: Top 10 Biological process exclusive to day4-7HEU 








GO:0006959 humoral immune response 4 252 0.0019 
GO:0019730 antimicrobial humoral response 3 143 0.0109 
GO:0065008 regulation of biological quality 7 3559 0.0146 
GO:0042742 defence response to bacterium 3 250 0.0280 
GO:0010823 negative regulation of mitochondrion 
organization 
2 50 0.0335 
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GO:0019731 antibacterial humoral response 2 47 0.0335 
GO:0050832 defence response to fungus 2 49 0.0335 
GO:0043687 post-translational protein modification 3 365 0.0349 
GO:1903201 regulation of oxidative stress-induced cell death 2 65 0.0349 
GO:0090559 regulation of membrane permeability 2 79 0.0383 
 
Table 19 Top 7 Biological process exclusive to day4-7HUU 








GO:0006887 exocytosis 9 774 1.87e-05 
GO:0043312 neutrophil degranulation 8 485 1.87e-05 
GO:0006880 intracellular sequestering of iron ion 2 5 0.00092 
GO:0051651 maintenance of location in cell 3 83 0.0034 
GO:0097237 cellular response to toxic substance 3 195 0.0353 
GO:0009636 response to toxic substance 4 468 0.0414 
GO:0006810 transport 11 4130 0.0434 
 
 
Table 20: Top 10 Biological processes common in all four groups . 













26 498 1.37e-19 
GO:004505
5 
regulated exocytosis 29 691 1.37e-19 
GO:004331
2 
neutrophil degranulation 25 485 8.08e-19 
GO:003294
0 
secretion by cell 31 959 1.02e-18 
GO:000177
5 
cell activation 29 1024 5.40e-16 
GO:004532
1 
leukocyte activation 27 894 2.15e-15 
GO:000225
2 
immune effector process 27 927 4.93e-15 
GO:000237
6 
immune system process 39 2370 7.86e-15 
GO:000695
5 




Chapter 4 Discussion  
The purpose of this study was to elucidate the microbiome in HEU and HUU infants using metaproteomic 
approaches. The study was designed to assess the microbial proteome as well as the host proteomes.  
Although the use metaproteomics allows for the identification of novel species in the gut, the study space is 
still plagued by a low rate of spectral matches identified, with only 7.6% and 4.9% of the MS/MS spectra 
identified in the birth and Day4-7 respectively. The loss of data is further exacerbated by the database 
generated by MetaNovo. Of the peptides uploaded, 134, 837,1401 and 2160 in Birth HUU, Birth HEU D4-
7HUU and D4-7HEU respectively were unassigned. Thus, a wealth of information is left out of the 
downstream analyses.  
 
4.1Taxonomic analysis of metaproteomic data   
From the results it is evident that there is a difference in the composition of the HEU infant microbiome 
compared to their HUU peers (Figure 9).Whilst it is not unexpected that a chronic inflammatory condition 
would result in an altered maternal microbiome, it is of interest to see how this affects the composition of 
the HEU infants compared to their HUU peers. 
This study revealed that the microbiome at birth of the HUU infants is primarily comprised of human proteins 
(Figure 11), whereas the HEU has a larger amount of microbiota present (Figure 14). The study also revealed 
that although the relative abundance of bacteria is less in HUU, the infant does not develop in a sterile 
environment, as the birth stool sample, the meconium, is often used as a proxy for the in-utero environment. 
Similar findings have been found and reported by (Jiménez et al., 2008; Collado et al., 2016; Zhu et al., 2018). 
The findings suggest that the healthy in utero environment is not heavily colonized by bacteria at birth. The 
increased bacterial presence in the HEU infant may be an indication of a compromised in utero environment. 
This study identified a large abundance of bacteria in the HUU at birth that belonged to the Family 
Bifidobacteriacae and Corynebacterceae, whereas Zhu and colleagues  (Zhu et al., 2018) identified a majority 
of bacteria that belonged to the family  Enterobactericae  in healthy Chinese infants. However, this study 
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investigated the microbiota of faecal samples in infants in South Africa, whereas Zhu and colleagues, 2018 
examined amniotic fluid. Nevertheless  a study of infant’s stool microbiome by (Nazmul Huda et al., 2014) 
also identified Actinobacteria , specifically Bifidobaceriaceae as the most abundant family in their cohort of 
infants in Bangladesh, similar to the family identified in this study. This suggests that the infant meconium 
has a unique microbiome that is independent of the amniotic fluid or the placenta and may not be the most 
accurate proxy of the in-utero environment as was previously believed. This then raises the question of what 
the origin of the gut infant microbiome in-utero is. 
 
The HEU and the HUU infant stool samples at birth both (Figure13 and Figure 16) revealed the presence of 
Metazoa, namely Cnidaria, Mollusca, Nematoda, Platyhelminthes, Portifera and Tardigrada, further 
affirming that the in-utero environment is not sterile. A study that was recently published indicated that 
infants inherited an immunologically derived protein that protected them from Helminth infections; these 
proteins were found to be passed on from the mother and were inherited across generations in murine 
models (Darby et al., 2019). This may explain the presence of these phyla derived peptides in the meconium. 
 
The hierarchical cluster analysis in Figure 24 shows that there are a large number of classes, and interestingly 
the HEU and HUU samples do not cluster according to exposure state. This reiterates the interindividual 
microbiota of each infant as well as reaffirms the diversity within each sample. The number of classes 
identified are less than at day 4-7 in both groups, because meconium has a low biomass. 
The results also show that there is a rapid shift in the microbial composition from birth (meconium) to Day 
4-7 in both the HEU and HUU infant. This shift may be due to the HBM microbiome at day 4-7, as there is an 
increase in bacterial biomass identified as well as in increase in the number of species of bacteria in the infant 
stool samples for the HEU and HUU infant. In the HUU at day 4-7 the majority of the peptides identified 
belong to the order Bifidobacteriales , with an increase in the number of Bifidobacterium species, 
Bifidobacteria , from two species at birth to twelve species at D4-7: B.adolescentis, B.asteroides, B.bifidum, 
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B.bohemicum, B.breve, B.callitrichos, B.longum with subspecies B.longum infantis B.mongoliense, 
B.pseudocatenulatum., B.psychraaerophilum, B.huminantium and B.scardovii.  The  B.scardovii strain has 
been associated with recurrent urinary tract infections (Barberis et al., 2012). 
In the HEU infants group the majority of peptides identified also belonged to the genus Bifidobacterium with 
an increase from six species at birth to eleven species identified at D4-7:  B. bifidum, B. bohemicum, B. breve, 
B. callitrichos, B. catenulatum, B. commune, B.kashiwanohense, B. longum, B. psuedocatenulatum, B. 
psychraerophilum and B. huminatium. 
Of the Bifidobacterium species identified, both HEU and HUU share the presence of several species: 
B.bifidum, B.bohemicum, B.breve, B.callitrichos, B.longum , B. psychraerophilum and B. huminatium . 
Interestingly the subspecies  B.longum infantis was only identified in the HUU infants , unlike other members 
of B .longum , the subspecies consumes a large number of Human milk oligosaccharides and is optimised for 
the infant gut microenvironment (Ward et al., 2007) 
The shift in the number of classes is probably due to the presence of HBM, as well as contact with the 
mother’s areolar, skin and the post uterine environment.  The heatmap shows that no one species is strongly 
associated with the microbiota. It reinforces the idea that the microbiome varies amongst individuals and 
that whilst these HEU infants have been shown to have adverse outcomes, there is no microbial signature as 
in the cases with other inflammatory diseases such as IBS or Crohn’s disease.  Any underlying differences at 
birth may be mitigated against by the introduction of HBM into the diet.  
The abundance of Bifidobacterium in the gut of infants has been linked to the digestion and processing of 
short chain fatty acids (SCFA). HBM has been shown to harbour a large amount of SCFA and thus 
Bifidobacterium presence in the infant gut is expected (Quigley et al., 2013).  
A likely source of the Bacterial biomass in the stools at day 4-7 is HBM. HBM  was the only source of nutrition 
for these infants as they were exclusively breast fed. Whilst HBM is believed to have a low biomass , it is 
established  that HBM is not sterile (Soto et al., 2014; Kumar et al., 2016) and that it would be the primary 
source of bacteria for the infant (Heikkilä and Saris, 2003). The presence of Bifidobacteria in HBM has 
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previously been established by Soto and colleagues (Turroni et al., 2012; Jost et al., 2014; Soto et al., 2014)  
Recently HBM microbiota was characterised and was found to be largely comprised of Acinetobacter, 
Enterobacter Staphylococcus and Streptococcus (Kordy et al., 2019).  Various studies have suggested that B. 
breve and B.longum are transferred directly from HBM into the infant’s gut (Solís et al., 2010; Soto et al., 
2014). Therefore, HBM may explain the presence of both species in the HEU and HUU infant. 
However, other studies have found that the microbial communities present in the mother’s  breast milk  and 
matched infants are different in composition (Pannaraj et al., 2017). Regardless it is likely the composition 
of the infant gut microbiome may be influenced by a combination of the mother’s areolar skin and breast 
milk (Pannaraj et al., 2017).  
Irrespective of the differences in the stool microbiota identification, the identification of Bifidobacteria in 
the infant’s stool samples was expected, as Bifidobacterium were first isolated from HBM fed infant’s stool 
in 1899 by Tissier (Weiss and Rettger, no date). The two species  B.bifidum and B.longum have been identified 
as the most abundant species in infants (Turroni et al., 2012). 
Some of the differences in the HEU microbiome could be associated with the mother’s HIV status (Bender et 
al., 2016). ) The average CD4 count for mothers in the HEU D4-7 samples was higher than the CD4 count in 
the HEU birth samples. Whilst most(47%) Appendix 3 of the HIV positive mothers were on the same HAARt 
regiment, 26% of the Mothers HAARt treatment was unknown, thus the variation may be due to the HAARt 
regimen as well as affected by how long the mother has been on ARV treatment. Biological confounders such 
as gender have been shown to influence the gut microbiome in infants(Cong et al., 2016), and thus the 
number of males and females within in group at each timepoint may influence the microbial composition.  
It also important to acknowledge that there is high interindividual  variability within infants (Falony et al., 
2016), even within the same clinical group classification. The infant microbiome is known to be very unstable 
and thus is modulated frequently. 
Whilst there may be a difference in the abundance of certain taxa that are represented in this study, it needs 
to be determined whether these differences might explain the difference in the altered immune function 
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that was previously described by (Garcia-Knight et al., 2015; Smith et al., 2017). Interestingly the introduction 
of HBM shifts the microbiome of both the HEU and HUU infant, making the difference in the diversity and 
abundance of the bacterial classes less prominent. 
4.2 Functional analysis of Metaproteomic data  
4.2.1 Peptide analysis. 
The UniPept online web-based platform has a Quick go plugin that allows the viewing of the pathways that 
are associated with the peptides that have been identified. The platform allows the navigation over the 
sunburst charts and generating pathway information related to: Biological process, Molecular Function and 
Cellular Component. The chart and tables can be viewed at different hierarchical levels.  
 
For this study, the hierarchical level interrogated was at Chordata level with investigation of the Go Terms 
associated with biological processes, the purpose being an investigation into the host proteins.  
At birth most of the Chordata peptides that were identified in the HEU were assigned to the GO term 
associated with neutrophil degranulation (GO:0043312), followed by innate immune response (GO:0045087) 
and immune responses (GO:0006955) (Table 8).  The top ten GO terms that are identified in the HEU infant 
are primarily concerned with the immune system, with six out of the ten identified being linked to immune 
function. Whereas in the HUU infant only four of the top ten are involved in the immune system responses 
/ activation. This may provide insight into the HEU infants immune responses if the immune activation and 
activity has already started in the womb (Kidzeru et al., 2014). In the HUU infant the top Go terms were 
neutrophil degranulation (GO:0043312), Proteolysis (GO:0006508), and Innate immune response 
(GO:0045087) (Table 9).  
Interestingly the top GO terms in the HEU infant at day 4-7 remain associated with immune system activity, 
with eight of the GO terms out of the top ten being dedicated to the immune system response (Table 10), 
whereas in the HUU the top biological processes are involved in metabolism activity, with no Go term 
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associated with the immune response (Table 11) . This finding is of interest as it lends evidence to the theory  
that the dysbiosis in the HEU infant alters the immune development (Kidzeru et al., 2014; Smith et al., 2017). 
This finding supports those of other studies and may elucidate the altered immune response of HEU even if 
they remain uninfected (Kidzeru et al., 2014; Smith et al., 2017). The findings may also explain the lower 
birthweights of the HEU infants. 
 
4.2.2 Protein analysis of metaproteomic data  
Panther protein classes  
Further pathway analysis was carried out on the Pantherid, using the protein-level identifications. The 
protein analysis on Panther dB was used to analyze the protein classes present in all groups at both time 
points. The most abundant protein class in both groups at both time points was hydrolase (PC000121). 
Hydrolase is a protein complex that is often found in the Liver and the Kidneys.  Whilst the most abundant 
class was Hydrolase, the protein class associated with defence /immunity /(PC000090) was present in the 
HEU and HUU infant at both time points, this indicates that immune function is an integral part of the infant’s 
microbiome. 
Perseus protein Analysis  
The protein analysis revealed that whilst there aren’t any significantly expressed proteins in either at each 
time point after multiple testing correction, there are proteins that are exclusively found in ether one of the 
groups. The use of multiple testing correction in proteomics is somewhat contentious since it can be overly 
stringent and has been shown to exclude many true identifications in in silico mock studies.  However, 
regardless of that, the proteins that are exclusive to each group at each time point may facilitate an 
understanding of the microbiome differences.  
Further functional analysis of the Human proteins exclusively found in each group at each time point was 
carried out on the String Db online platform. In HEU infants the most abundant GO Term descriptions were 
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associated with immune function, with neutrophil degranulation (GO: 0043312) and humoral immune 
response (GO:000695) in birth and Day 4-7 respectively. However, String. dB was only able to identify three 
GO terms in the Birth HEU and seven GO terms in the Day 4-7 HUU group. 
Both the groups experience an increase in the number of genes that were identified, however unlike the 
QuickGO analysis on UniPept most of the proteins are not associated with immune response. Instead in all 
cases most of the proteins were associated with Cellular process.  
This difference in the biological process data highlights one the shortcomings of microbiome studies. The 
platforms that are used to analyze the data can generate very different results for the same set of data. This 
phenomenon was recently  discussed by Peters and colleagues (Peters et al., 2019a), where they found that 
the same data analysed on UniPept and MEGAN  gave different results. One of the reasons these differences 
are observed in our data is due to the nature of the platforms. The differences observed in the biological 
process analysis on the UniPept platform vs Pantherdb.org is due to the difference in the searches. The 
UniPept functions at a peptide-centric level, assigning peptides to the lowest common ancestor (LCA) for 
identification, whilst the analysis on Panther dB relies on protein level identification with all non-human 
proteins filtered out. This may have resulted in the loss of some human protein that were erroneously 
attributed to non-human primates in MetaNovo.  
Both methods have their advantages and disadvantages. The advantage in using Pantherdb is the platform’s 
ability to assign proteins to Gene Ontologies as well as to match the proteins to genes. This allows for a more 
accurate inference of function in the human host. Another advantage of Pantherdb is that the database is 
curated with genomic data and has been optimized for gene-function association. Whilst the QuickGo plugin 
is useful in that functional analysis and taxonomic analysis can be carried out on a single platform, the issue 
with peptide-centric analysis is the possibility of a single peptide sequence belonging to more than one 
protein. This makes it challenging to accurately assign peptides to functions.  
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4.3 Limitations  
Whilst metaproteomics allows us to study the interaction between the host proteins as well as the 
microbiota, there are still limitations. One of the greatest limitations is the lack of a standardised protocol 
for the stool sample preparation and analysis (Lai et al., 2019; Peters et al., 2019a). The methods used for 
samples preparation has a great bearing on the microbiota identified.  
Another limitation is the masking of low abundance proteins in mass spectrometry. Low abundance proteins 
are often not detected and can be missed with further downstream analysis. Thus, clinically relevant 
microbial and host interplay may be missed due to this.  
Furthermore the reliance of a well curate database to identify the microbiota and the host proteins is a 
limitation, because it is known that upon downstream analysis two very distinct results can be generated 
using the exact same samples and files, as was witnessed by (Hamady et al., 2009; Peters et al., 2019b).  
There is also batch to batch variation that must be accounted for due to human error and that may affect 
the quality control.  
The database MetaNovo that was used erroneously identified human derived proteins as non-human 
primates i.e. macaque, and this needs to be taken into consideration as this suggests that there is room for 
error in the identification of the microbial peptides. Whilst UniPept can identify to LCA (lowest common 
ancestor) as well as species, the safer method to analyse the data was to look at class of bacteria and phyla 
instead of species as this would increase the error rate. Taking this into account pathogenically relevant 
species may be missed upon investigation. One way to overcome the possible misidentification is to manually 
verify the spectra, to ensure what is identified actually exist within the sample.  
A major limitation of the study itself was the number of samples available for analysis a total of 63 samples 
were analysed as part of this sub study. The limited number of samples means there was limited statistical 
power. Another limitation that must be accounted for which also relates to the curation of the database, is 
the number of unassigned peptide sequences, which is one of the disadvantages of using a peptide centric 
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downstream analysis tool. However, it does allow for the identification of unique microbes that were 
previously difficult to identify in microbiome studies. 
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Chapter 5. Conclusion and recommendations  
From the above study there are underlying differences in the microbiome of HEU and HUU infants. These 
differences are most evident at birth suggesting a great influence in the womb. Whilst these differences can 
be seen at birth it is still not clear what the underlying mechanism for the differences is. It could be a host of 
factors, such as the mother’s HIV status, the presence of ARV’s and the vaginal microbiome of the mother 
being amongst a few of the factors that may explain these differences. Interestingly the microbiome 
differences in the HUU and HEU groups was less starkly different at day 4-7 indicating the important role of 
HBM in shaping the infant’s microbiome. This finding suggests that the presence of HBM could facilitate 
correcting the underlying differences in the two groups. 
 
A future study comparing the mother’s HBM and vaginal microbiome to the infant’s gut microbiome, as well 
as a longitudinal study would be beneficial in understanding the differences seen in these two groups.  Also, 
a larger number of infant mothers diads would be able to generate a statistically powerful study, however 
the clinical relevance of this study is still realized. There is a trend towards microbiomes colonised by 
different microbiota. The amniotic fluid, placenta and vaginal microbiome of infant mother pairs would allow 
us to investigate the origin of the in-uterine environment. Examining the HBM and the infant stool 
microbiome in a longitudinal study would also generate data on colonisation and changes in the microbiome 
in the HEU infant. The microbiota could also be investigated and quantified by use of spectral counting to 
reveal any quantitative differences between the groups investigated.   
 
A metagenomic approach would also be beneficial to understanding the host and microbe interactions. it 
would also allow for the comparison of the genetic data and the proteomic data. The metabolomic fractions 
from the sample prep should be analysed as well, as this would allow for a comparison of the protein pathway 
data generated from the proteome with the data generated by the metabolites. A metabolomics study of 
the HBM of the mothers in the study would allow for a comparative analysis of the stool metabolome of 
both the infant and the mother, as well as the HBM metabolome. 
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Formal 
House  Yes Yes Yes 
Single/ never 
married  
138 HEU D4-7 
Mal
e 39 29 Secondary/ High School Unemployed  
Formal 
House  Yes Yes Yes 
Single/ never 
married  
140 HEU D4-7 
Fem
ale 37 33 Secondary/ High School Salaried Private  
Formal 
House  Yes Yes Yes Married  
 
142 HEU D4-7 
Mal
e 37 25 Secondary/ High School Salaried Private  
Formal 
House  Yes Yes Yes 
Single/ never 
married  
143 HEU D4-7 
Fem
ale 37 27 Secondary/ High School Unemployed  Shack Yes Yes No 
Single/ never 
married  
156 HEU D4-7 
Mal
e 38 30 Secondary/ High School 
Domestic/ 
housekeeper  Shack Yes Yes No 
Single/ never 
married  
157 HEU D4-7 
Mal




House  Yes Yes Yes 
Single/ never 
married  
159 HEU D4-7 
Mal
e 39 19 Secondary/ High School Unemployed  
Formal 
House  Yes Yes Yes 
Single/ never 
married  
161 HEU D4-7 
Mal
e 39 26 Secondary/ High School Salaried Private  Shack Yes Yes No 
Single/ never 
married  
302 HU Birth 
Mal
e 36 27 Secondary/ High School Salaried Private  
Formal 
House  Yes Yes Yes 
Single/ never 
married  
305 HU D4-7 
Mal
e 38 26 Secondary/ High School Unemployed  Shack No No No 
Single/ never 
married  
307 HU Birth 
Mal
e 39 19 Secondary/ High School Unemployed  Shack Yes No No 
Single/ never 
married  
308 HU D4-7 
Mal
e 38 27 Secondary/ High School Unemployed  
Formal 
House  Yes Yes Yes 
Single/ never 
married  
309 HU D4-7 
Fem
ale 40 32 Secondary/ High School Unemployed  Shack Yes Yes No 
Single/ never 
married  
312 HU D4-7 
Fem
ale 41 36 Secondary/ High School Unemployed  Shack No No No 
Single/ never 
married  
314 HU D4-7 
Mal
e 39 29 Secondary/ High School Unemployed  Shack Yes Yes No 
Single/ never 
married  
315 HU D4-7 
Mal
e 39 23 
Higher Education( College/ 
Diploma/etc) Student 
Formal 
House  Yes Yes Yes 
Single/ never 
married  
316 HU D4-7 
Fem
ale 37 19 Secondary/ High School Student Shack Yes Yes No 
Single/ never 
married  
318 HU D4-7 
Fem
ale 39 30 Secondary/ High School Unemployed  Shack Yes Yes No Married  
 
319 HU D4-7 
Fem
ale 38 35 Secondary/ High School Unemployed  
Formal 
House  Yes Yes Yes 
Living 
together  
320 HU D4-7 
Fem
ale 39 32 Secondary/ High School Unemployed  Shack Yes Yes No 
Single/ never 
married  
325 HU D4-7 
Fem
ale 39 24 Secondary/ High School 
Domestic/ 
housekeeper  Shack No No No 
Living 
together  
332 HU D4-7 
Mal




House  Yes Yes No 
Single/ never 
married  
337 HU D4-7 
Mal
e 37 28 Secondary/ High School Salaried Private  
Formal 
House  Yes Yes Yes 
Single/ never 
married  
345 HU D4-7 
Fem
ale 39 24 Secondary/ High School House Wife Shack Yes Yes Yes Married  
347 HU D4-7 
Mal
e 39 19 Secondary/ High School Unemployed  Shack Yes Yes No 
Single/ never 
married  
350 HU D4-7 
Mal
e 37 24 Secondary/ High School Unemployed  Shack Yes Yes No 
Single/ never 
married  
354 HU Birth 
Fem
ale 38 24 Secondary/ High School Salaried Private  
Formal 
House  Yes Yes Yes 
Single/ never 
married  
357 HU Birth 
Mal
e 39 22 Secondary/ High School Salaried Private  
Formal 
House  Yes Yes Yes 
Single/ never 
married  
359 HU Birth 
Mal
e 40 26 Secondary/ High School Unemployed  Shack Yes Yes Yes 
Single/ never 
married  
360 HU D4-7 
Fem
ale 40 26 Secondary/ High School 
Domestic/ 
housekeeper  Shack Yes Yes No 
Single/ never 
married  
365 HU Birth 
Fem
ale 38 28 Secondary/ High School Unemployed  
Formal 
House  Yes Yes Yes Married  
374 HU Birth 
Mal
e 37 24 Secondary/ High School Self Employed  
Formal 
House  Yes Yes No Married  
377 HU D4-7 
Fem
ale 40 22 Secondary/ High School Student 
Formal 
House  Yes Yes Yes 
Single/ never 
married  
381 HU D4-7 
Fem
ale 39 26 Secondary/ High School Unemployed  
Formal 




383 HU D4-7 
Mal
e 38 23 Secondary/ High School Unemployed  
Formal 
House  Yes Yes No 
Single/ never 
married  
387 HU D4-7 
Mal
e 39 19 Secondary/ High School Unemployed  Shack Yes No No 
Single/ never 
married  
389 HU D4-7 
Mal
e 38 23 Secondary/ High School Salaried Private  
Formal 










A.3 Clinical information of infant mother diads recruited for study 
Sam
ple 
















































478 Tribuss FDC 21 
008 HEU Birth Femal
e 




568 Tribuss 26 
009 HEU D4-7 Femal
e 




470 unknown 30 




830 unknown 36 





















017 HEU D4-7 Femal
e 
2720 46 31 36,7 38 Yes  BC
G 
  353 unknown 26 
018 HEU D4-7 Femal
e 







020 HEU Birth Femal
e 







026 HEU Birth Femal
e 




456 TDF,FTC,EFV 30 
038 HEU D4-7 Femal
e 







054 HEU Birth Femal
e 




227 unknown 28 
 
055 HEU Birth Femal
e 











165 FTC,EFV,TDF 25 







063 HEU Birth Femal
e 




433 TDF,FTC,EFV 22 
066 HEU Birth Femal
e 







071 HEU Birth Femal
e 




595 unknown 29 
078 HEU D4-7 Femal
e 




350 TDF,FTC,EFV 35 







088 HEU Birth Femal
e 




388 unknown 24 
092 HEU D4-7 Femal
e 




795 unknown 29 
100 HEU Birth Femal
e 




366 unknown 23 




319 FTC,EFV,TDF 29 




493 TDF,FTC,EFV 32 







140 HEU D4-7 Femal
e 




715 unknown 33 








143 HEU D4-7 Femal
e 




685 TDF,FTC,EFV 27 
































N/A N/A 27 




N/A N/A 26 




N/A N/A 19 




N/A N/A 27 
309 HU D4-7 Femal
e 




N/A N/A 32 
312 HU D4-7 Femal
e 




N/A N/A 36 




N/A N/A 29 




N/A N/A 23 
316 HU D4-7 Femal
e 




N/A N/A 19 
318 HU D4-7 Femal
e 




N/A N/A 30 
319 HU D4-7 Femal
e 




N/A N/A 35 
 
320 HU D4-7 Femal
e 




N/A N/A 32 
325 HU D4-7 Femal
e 




N/A N/A 24 




N/A N/A 28 




N/A N/A 28 
345 HU D4-7 Femal
e 




N/A N/A 24 




N/A N/A 19 




N/A N/A 24 
354 HU Birth Femal
e 




N/A N/A 24 




N/A N/A 22 




N/A N/A 26 
360 HU D4-7 Femal
e 




N/A N/A 26 
365 HU Birth Femal
e 




N/A N/A 28 




N/A N/A 24 
377 HU D4-7 Femal
e 




N/A N/A 22 
381 HU D4-7 Femal
e 




N/A N/A 26 




N/A N/A 23 
 




N/A N/A 19 




N/A N/A 23 
 
 
B.1) Concentration and TIC of samples that were processed  
STOOL 
LOG  STATUS  
Concentration 
(ug\uL) Timepoint  TIC  
Sample          
4 HEU 3,75 Birth 9,44E+09 
8 HEU 2,391 Birth 9,76E+08 
9 HEU 4,103 D4-7 5,83E+09 
10 HEU (-) D4-7 3,66E+09 
16 HEU 3,56 D4-7 3,78E+08 
17 HEU 8,61 D4-7 3,25E+09 
18 HEU 5,452 D4-7 8,29E+09 
20 HEU 0,183 Birth 5,43E+09 
26 HEU 3,257 Birth 6,98E+09 
38 HEU (-) D4-7 4,21E+09 
54 HEU (-) Birth 4,92E+09 
55 HEU (-) Birth 3,55E+09 
62 HEU 3,524 Birth 3,37E+09 
63 HEU 1,111 Birth 9,64E+08 
66 HEU 0,113 Birth 12200000 
71 HEU 0,939 Birth 9,76E+08 
81 HEU (-) Birth 9,98E+08 
88 HEU 3,98 Birth 1,05E+09 
92 HEU 1,562 D4-7 5,74E+09 
100 HEU 5,77 Birth 1,83E+09 
121 HEU 1,699 D4-7 5,81E+09 
127 HEU 1,836 D4-7 5,6E+09 
140 HEU 5,61 D4-7 1,21E+09 
142 HEU 6,34 D4-7 1,38E+08 
143 HEU 0,34 D4-7 5,73E+09 
156 HEU 6,589 D4-7 1,22E+08 
159 HEU 4,69 D4-7 1,05E+09 
161 HEU 2,15 D4-7 2,19E+09 
302 HU 5,866 Birth 5,13E+09 
305 HU (-) D4-7 2,81E+09 
307 HU 3,404 Birth 7,87E+09 
308 HU 5,188 D4-7 4,95E+09 
309 HU 1,754 D4-7 9,94E+08 
312 HU 1,73 D4-7 3,62E+09 
314 HU 1,64 D4-7 1,97E+09 
315 HU 7,83 D4-7 1,47E+08 
319 HU 5,15 D4-7 1,28E+08 
320 HU 1,83 D4-7 1,4E+09 
325 HU 0,267 D4-7 2,13E+08 
332 HU 3,027 D4-7 8,89E+09 
337 HU 1,892 D4-7 1,05E+10 
 
347 HU 1,304 D4-7 2,1E+09 
350 HU (-) D4-7 9,65E+08 
354 HU 2,268 Birth 4,66E+09 
357 HU 3,8 Birth 1,63E+09 
359 HU 8,99 Birth 1,55E+08 
360 HU 6,88 D4-7 1,49E+08 
365 HU 8,48 Birth 1,01E+09 
374 HU (-) Birth 5,6E+09 
377 HU 3,98 D4-7 1,29E+09 
381 HU 6,54 D4-7 2,2E+09 
383 HU 7,86 D4-7 9,61E+08 
387 HU 0,836 D4-7 3,06E+09 
389 HU 2,91 D4-7 1,49E+08 
 
 
 
